All In Biotech

Drug Trial Radar · NCT05769257

A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery

A Phase 2 Multi-Center Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery Using the da Vinci® Surgical System With Firefly® Fluorescent Imaging

Last checked: Nov 19, 2026Latest source record: May 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

12

Actual

Start

Jun 14, 2023

Primary completion

Mar 18, 2024

Study completion Apr 4, 2024

Sponsor

Lead sponsor
Intuitive SurgicalIndustry
Sponsor type
Industry
First posted
Mar 15, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the safety and feasibility of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation

Conditions

  • Ureter Injury

Interventions

  • IS-001Drug

    Intravenous injection of IS-001 investigational drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate ureter visualization by Independent ReaderTime frame: 10 minutes after first IS-001 injection during surgery
  2. Evaluate ureter visualization by Independent ReaderTime frame: 30 minutes after first IS-001 injection during surgery
  3. Evaluate ureter visualization by Independent ReaderTime frame: 45 minutes after first IS-001 injection during surgery
  4. Evaluate ureter visualization by Independent ReaderTime frame: 10 minutes after second IS-001 injection during surgery
  5. Evaluate ureter visualization by Independent ReaderTime frame: 30 minutes after second IS-001 injection during surgery
  6. Evaluate ureter visualization by Independent ReaderTime frame: 45 minutes after second IS-001 injection during surgery

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • St. David's North Austin Medical Center

    Austin, Texas

  • MultiCare Tacoma General Hospital

    Tacoma, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.